Advertisement
Research Article| Volume 9, ISSUE 3, P369-392, September 1989

Laboratory Diagnosis of Human Immunodeficiency Virus Infection

  • Donald S. Burke
    Correspondence
    Corresponding author: Department of Academic Affairs, Walter Reed Army Institute of Research, Walter Reed Army Medical Center, Washington, D.C. 20307-5100.
    Affiliations
    Director, Division of Retrovirology, Walter Reed Army Institute of Research, Walter Reed Army Medical Center, Washington, DC
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30609-7
Laboratory Diagnosis of Human Immunodeficiency Virus Infection
Previous ArticlePreface
Next ArticleImmunologic Evaluation of Persons Infected with Human immunodeficiency Virus
      This paper is only available as a PDF. To read, Please Download here.
      The technical issues relevant to the laboratory diagnosis of human immunodeficiency virus (HIV) infection are dealt with. Performance characteristics of the various HIV diagnostic assays are presented.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Abbott M.A.
        • Poiesz B.J.
        • Byrne B.C.
        • et al.
        Enzymatic gene amplification: Qualitative and quantitative methods for detecting proviral DNA amplified in vitro.
        J Infect Dis. 1988; 158: 1158
        • Albert J.
        • Bredberg U.
        • Chiodi F.
        • et al.
        A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB.
        AIDS Res Hum Retroviruses. 1987; 3: 3
        • Albert J.
        • Gaines H.
        • Sonnerborg A.
        • et al.
        Isolation of human immunodeficiency virus (HIV) from plasma during primary HIV infection.
        J Med Virol. 1987; 23: 67
        • Allain J.P.
        • Laurian Y.
        • Paul D.A.
        • et al.
        Long-term evaluation of HIV antigen and anti bodies to p41 in patients with hemophilia.
        N Engl J Med. 1987; 317: 1114
        • Allan J.S.
        • Coligan J.E.
        • Barin F.
        • et al.
        Major glycoprotein antigens that induce antibodyies in AIDS patients are encoded by HTLV-III.
        Science. 1985; 228: 1091
        • Ameglio F.
        • Dolei A.
        • Benedetto A.
        • et al.
        Antibodies reactive with nonpolymorphicepitopes on HLA molecules interfere in screening tests for the human immunodeficiency virus [letter].
        J Infect Dis. 1987; 156: 1034
        • Anand R.
        • Siegal F.
        • Reed C.
        • et al.
        Noncytocidal natural variants of human immunodeficiency virus isolated from AIDS patients with neurological disorders.
        Lancet. 1987; 2: 234
        • Andiman W.A.
        Virologic and serologic aspects of human immunodeficiency virus infection in infants and children.
        Semin Perinatol. 1989; 13: 16
        • Arya S.K.
        • Gallo R.C.
        • Hahn B.H.
        • et al.
        Homology of genome of AIDS-associated virus with genomes of human T-cell leukemia virus.
        Science. 1984; 225: 927
        • Asjo B.
        • Albert J.
        • Karlsson A.
        • et al.
        Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection.
        Lancet. 1986; 2: 660
        • Backer U.
        • Weinauer F.
        • Gathof G.
        HIV antigen screening in blood donors.
        Lancet. 1987; 2: 1213
        • Barin F.
        • McLane M.F.
        • Allan J.S.
        • et al.
        Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients.
        Science. 1985; 228: 1094
        • Barnes D.M.
        New questions about AIDS test accuracy [news].
        Science. 1987; 238: 884
        • Barry M.J.
        • Cleary P.D.
        • Fineberg H.V.
        Screening for HIV infection: Risks, benefits, and the burden of proof.
        Law Med Health Care. 1986; 14: 259
        • Bedarida G.
        • Gambie G.
        • D’Agostino F.
        HIV IgM antibodies in risk groups who are seronegative on Elisa testing [letter].
        Lancet. 1986; 2: 570
        • Bender B.S.
        • Davidson B.L.
        • Kline R.
        • et al.
        Role of the mononuclear phagocyte system in the immunopathogenesis of human immunodeficiency virus infection and the acquired immunodeficiency syndrome.
        Rev Infect Dis. 1988; 10: 1142
        • Benn S.
        • Rutledge R.
        • Folks T.
        • et al.
        Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire.
        Science. 1985; 230: 949
        • Blanton M.
        • Balakrishnan K.
        • Dumaswala U.
        • et al.
        HLA antibodies in blood donors with reactive screening tests for antibody to the immunodeficiency virus.
        Transfusion. 1987; 27: 118
        • Borkowsky W.
        • Paul D.
        • Bebenroth D.
        • et al.
        Human immunodeficiency virus infections in infants negative for anti-HIV by enzyme-linked immunoassay.
        Lancet. 1987; 1: 1168
        • Burke D.S.
        • Brandt B.L.
        • Redfield R.R.
        • et al.
        Diagnosis of human immunodeficiency virus infection by immunoassay using a molecularly cloned and expressed virus envelope polypeptide.
        Ann Intern Med. 1987; 106: 671
        • Burke D.S.
        • Brundage J.F.
        • Redfield R.R.
        • et al.
        Measurement of the false positive rate in a screening program for human immunodeficiency virus infections.
        N Engl J Med. 1988; 319: 961
        • Burke D.S.
        • Redfield R.R.
        False-positive Western blot tests for antibodies to HTLV-III [letter].
        JAMA. 1986; 256: 347
        • Burke D.S.
        • Redfield R.R.
        Transmission of human immunodeficiency virus (HIV) [letter].
        N Engl J Med. 1988; 318: 1202
        • Burke D.S.
        • Redfield R.R.
        • Putman P.
        • et al.
        Variations in Western blot banding patterns of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus.
        J Clin Microbiol. 1987; 25: 81
        • Carne C.A.
        • Tedder R.S.
        • Smith A.
        • et al.
        Acute encephalopathy coincident with sero conversion for anti-HTLV-III.
        Lancet. 1985; 2: 1206
        • Chang K.S.
        • Wand L.C.
        • Gao C.L.
        • et al.
        Concomitant infection of HTLV-I and HIV-I: Prevalence of IgG and IgM antibodies in Washington, D.C. area.
        Eur J Epidemiol. 1988; 4: 426
        • Chiodi F.
        • Albert J.
        • Olausson E.
        • et al.
        Isolation frequency of human immunodeficiency virus from cerebrospinal fluid and blood of patients with varying severity of HIV infection.
        AIDS Res Hum Retroviruses. 1988; 4: 351
        • Chiodi F.
        • Bredberg-Raden U.
        • Biberfeld G.
        • et al.
        Radioimmunoprecipitation and Western blotting with sera of human immunodeficiency virus infected patients: a comparative study.
        AIDS Res Hum Retroviruses. 1987; 3: 165
        • Chiodi F.
        • von Gegerfeldt A.
        • Albert J.
        • et al.
        Site-directed Elisa with synthetic peptides representing the HIV transmembrane glycoprotein.
        J Med Virol. 1987; 23: 1
        • Chou M-J
        • Lee T-H
        • Hatzakis A.
        • et al.
        Antibody responses in early human immunode ficiency virus type 1 infection in hemophiliacs.
        J Infect Dis. 1988; 157: 805
        • Clavel F.
        • Guetard D.
        • Brun-Vezinet F.
        • et al.
        Isolation of a new human retrovirus from West African patients with AIDS.
        Science. 1986; 233: 343
        • Coombs R.
        • Gjerset G.
        • Nikora B.
        • et al.
        Isolation of human immunodeficiency virus (HIV) from the peripheral blood lymphocytes (PBL) and plasma of asymptomatic and symptomatic HIV seropositive hemophiliacs.
        CDC AIDS Weekly. 1988; 4: 17
        • Creemers P.C.
        • O’Shaughnessy M.
        • Boyko W.J.
        Analysis of absolute T helper cell number and cellular immune defects in HIV antibody positive and negative homosexual men.
        AIDS Res Hum Retroviruses. 1988; 4: 269
        • Damato J.
        • Fipps D.R.
        • Redfield R.R.
        • et al.
        The Department of the Army quality assurance program for human immunodeficiency virus antibody testing.
        Lab Med. 1988; 19: 577
        • De Rossi A.
        • Amadori A.
        • Chieco-Bianchl L.
        • et al.
        Polymerase chain reaction and in vitro antibody production for early diagnosis of paediatric HIV infection [letter].
        Lancet. 1988; 1: 278
        • Di Marzo Veronese F.
        • Copeland T.D.
        • Oroszlan S.
        • et al.
        Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24.
        J Virol. 1988; 62: 795
        • Di Marzo Veronese F.
        • Copeland T.D.
        • Devico A.L.
        • et al.
        Characterization of highly immunogenic p66/p52 as the reverse transcriptase of HTLV-IH/LAV.
        Science. 1986; 231: 1289
        • Evans L.A.
        • McHugh T.M.
        • Stites D.P.
        • et al.
        Differential ability of human immunodeficiency virus isolates to productively infect human cells.
        J Immunol. 1987; 138: 3415
        • Fling J.A.
        • Fischer Jr., J.R.
        • Boswell R.N.
        • et al.
        The relationship of serum IgA concentration to human immunodeficiency virus (HIV) infection: A cross-sectional study of HIV-seropositive individuals detected by screening in the United States Air Force.
        J Allergy Clin Immunol. 1988; 82: 965
        • Food and Drug Administration
        Safety of immune globulins in relation to HTLV-III.
        FDA Drug Bull. 1986; 16: 3
        • Francis D.
        • Chin J.
        • Dan B.B.
        The prevention of acquired immunodeficiency syndrome in the United States: An objective strategy for medicine, public health, business, and the community.
        JAMA. 1987; 257: 1357
        • Fuchs D.
        • Reibnegger G.
        • Wachter H.
        • et al.
        Neopterin levels correlating with the Walter Reed staging classification in human immunodeficiency virus (HIV) infection.
        Ann Intern Med. 1987; 107: 784
        • Gaines H.
        • von Sydow M.
        • Parry J.V.
        • et al.
        Detection of immunoglobulin M antibody in primary human immunodeficiency virus infection.
        Aids. 1988; 2: 11
        • Gallo R.C.
        The AIDS virus.
        Sci Am. 1987; 256: 46
        • Garrett A.J.
        • Seagroatt V.
        • Supran E.M.
        • et al.
        Measurement of antibodies to human immunodeficiency virus: An international collaborative study to evaluate WHO reference sera.
        Bull WHO. 1988; 66: 197
        • Gartner S.
        • Markovits P.
        • Markovitz D.M.
        • et al.
        The role of macrophages in HTLV-Ш/LAV infection.
        Science. 1986; 233: 215
        • Gebel H.M.
        • Anderson J.E.
        • Gottschalk L.R.
        • et al.
        Determination of helper-suppressor T-cell ratios [letter].
        N Engl J Med. 1987; 316: 113
        • Gelderblom H.R.
        • Hausmann E.H.S.
        • Ozel M.
        • et al.
        Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins.
        Virology. 1987; 156: 171
        • Gendelman H.E.
        • Orenstein J.
        • Martin M.A.
        • et al.
        Efficient isolation and propagation of biologically novel human immunodeficiency virus onto CSF-1 stimulated macrophages.
        J Exp Med. 1988; 167: 1428
        • Gnann J.W.
        • McCormick J.B.
        • Mitchell S.
        • et al.
        Synthetic peptide immunoassay distinguishes HIV type 1 and type 2 infections.
        Science. 1987; 237: 1346
        • Gnann J.W.
        • Schwimmbeck P.L.
        • Nelson J.A.
        • et al.
        Diagnosis of AIDS by using a 12-aminoacid peptide representing an immunodominant epitope of the human immunodeficiency virus.
        J Infect Dis. 1987; 156: 261
        • Goedert J.J.
        • Eyster M.E.
        • Biggar R.J.
        • et al.
        Heterosexual transmission of human immunodeficiency virus: Association with severe depletion of T-helper lymphocytes in men with hemophilia.
        AIDS Res Hum Retroviruses. 1987; 3: 355
        • Goudsmit J.
        • Lange J.M.A.
        • Krone W.J.A.
        • et al.
        Pathogenesis of HIV and its implications for serodiagnosis and monitoring of antiviral therapy.
        J Virol Meth. 1987; 17: 19
        • Goudsmit J.
        • de Wolf F.
        • Paul D.A.
        • et al.
        Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection.
        Lancet. 1986; 2: 177
        • Griffith B.P.
        Principles of laboratory isolation and identification of the human immunodeficiency virus (HIV).
        Yale J Biol Med. 1987; 60: 575
        • Healey D.S.
        • Maskill W.J.
        • Neate E.V.
        • et al.
        A preliminary evaluation of five HIV antigen detection assays.
        J Virol Meth. 1988; 20: 115
        • Ho D.D.
        • Pomerantz R.J.
        • Kaplan J.C.
        Pathogenesis of infection with HIV.
        New Engl J Med. 1987; 317: 278
        • Ho D.D.
        • Sarngadharan M.G.
        • Resnick L.
        • et al.
        Primary human T-lymphotropic virus type III infection.
        Ann Intern Med. 1985; 103: 880
        • Hollander H.
        • Levy J.A.
        Neurologic abnormalities and recovery of human immunode ficiency virus from cerebrospinal fluid.
        Ann Intern Med. 1987; 106: 692
        • Jendis J.B.
        • Tomasik Z.
        • Hunziker U.
        • et al.
        Evaluation of diagnostic tests for HIV infection in infants born to HIV-infected mothers in Switzerland.
        Aids. 1988; 2: 273
        • Kanki P.J.
        • M’Boup S.
        • Ricard D.
        • et al.
        Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa.
        Science. 1987; 236: 827
        • Kwok S.
        • Mack D.H.
        • Mullis K.B.
        • et al.
        Identification of human immunodeficiency virus sequences by using in vitro enzymatic amplification and oligomer cleavage detection.
        J Virol. 1987; 61: 1690
        • Lacey J.N.
        • Forbes M.A.
        • Waugh M.A.
        • et al.
        Serum beta2-microglobulin and human immunodeficiency virus infection.
        Aids. 1987; 1: 123
        • Lange J.
        • Goudsmit J.
        Decline of antibody reactivity to HIV core protein secondary to increased production of HIV antigen [letter].
        Lancet. 1987; 1: 448
        • Lange J.M.
        • Goudsmit J.
        • De Wolf F.
        • et al.
        Serological markers in HIV infection.
        Ann Med Interne (Paris). 1988; 139: 80
        • Lange J.M.
        • Parry J.V.
        • de Wolf F.
        • et al.
        Diagnostic value of specific IgM antibodies in primary HIV infection.
        Aids. 1988; 2: 31
        • Levy J.A.
        Indirect immunofluorescence assays can readily detect antibodies to the human immunodeficiency virus [letter].
        JAMA. 1987; 257: 1176
        • MacDonell K.B.
        • Chmiel J.S.
        • Goldsmith J.
        • et al.
        Prognostic usefulness of the Walter Reed staging classification for HIV infection.
        J Aids. 1988; 1: 367
        • Macy E.M.
        • Adelman D.C.
        Abnormal T-cell subsets in normal persons [letter].
        N Engl J Med. 1988; 319: 1608
        • Mayer K.H.
        • Stoddard A.M.
        • McCusker J.
        • et al.
        Human T-lymphotropic virus type III in high-risk, antibody-negative homosexual men.
        Ann Intern Med. 1986; 104: 194
        • McCormick J.B.
        • Krebs J.W.
        • Mitchell S.W.
        • et al.
        Isolation of human immune deficiency virus from African AIDS patients and from persons without AIDS or IgG antibody to human immune deficiency virus.
        Am J Trop Med Hyg. 1987; 36: 102
        • McHugh T.M.
        • Stites D.P.
        • Casavant C.H.
        • et al.
        Evaluation of the indirect immunofluo-rescence assay as a confirmatory test for detecting antibodies to the human immunodeficiency virus.
        Diagn Immunol. 1986; 4: 233
        • McHugh T.M.
        • Stites D.P.
        • Busch M.P.
        • et al.
        Relation of circulating levels of human immunodeficiency virus (HIV) antigen, antibody to p24, and HIV-containing immune complexes in HIV-infected patients.
        J Infect Dis. 1988; 158: 1088
        • Muller F.
        • Muller K.H.
        Detection of anti-HIV-1 immunoglobulin M antibodies in patients with serologically proved HIV-1 infection.
        Infection. 1988; 16: 115
        • Ou C-H
        • Kwok S.
        • Mitchell S.W.
        • et al.
        DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells.
        Science. 1988; 239: 295
        • Parry J.V.
        • Mortimer P.P.
        Place of IgM antibody testing in HIV serology [letter].
        Lancet. 1986; 2: 979
        • Ranki A.
        • Johansson E.
        • Krohn K.
        Interpretation of antibodies reacting solely with human retroviral core proteins.
        N Engl J Med. 1988; 318: 448
        • Ranki A.
        • Walles S-L
        • Krohn M.
        • et al.
        Long latency precedes overt seroconversion in sexually transmitted human immunodeficiency virus infection.
        Lancet. 1987; 2: 589
        • Rayfield M.
        • DeCock K.
        • Heyward W.
        • et al.
        Mixed human immunodeficiency virus (HIV) infection in an individual: Demonstration of both HIV type 1 and type 2 proviral sequences by using polymerase chain reaction.
        J Infect Dis. 1988; 158: 1170
        • Reddy M.M.
        • Grieco M.H.
        Elevated soluble interleukin-2 receptor levels in serum of human immunodeficiency virus infected populations.
        AIDS Res Hum Retroviruses. 1988; 4: 115
        • Re M.C.
        • Furlini G.
        • Baldassarri B.
        • et al.
        Serological study of subjects with seroconvert sion to human immunodeficiency virus.
        Eur J Clin Microbiol Infect Dis. 1988; 7: 144
        • Redfield R.R.
        • Burke D.S.
        HIV infection: The clinical picture.
        Sci Am. 1988; 259: 90
        • Redfield R.R.
        • Wright D.C.
        • Tramont E.C.
        The Walter Reed staging classification for HTLV-III/LAV infection.
        N Engl J Med. 1986; 314: 131
        • Reesink W.H.
        • Huisman J.G.
        • Gonsalves M.
        • et al.
        Evaluation of six enzyme immunoas says for antibody against human immunodeficiency virus.
        Lancet. 1986; 2: 483
        • Richman D.D.
        • McCutchan J.A.
        • Spector S.A.
        Detecting human immunodeficiency virus RNA in peripheral blood mononuclear cells by nucleic acid hybridization.
        J Infect Dis. 1987; 156: 823
        • Salahuddin S.Z.
        • Groopman J.E.
        • Markham P.D.
        • et al.
        HTLV-III in symptom-free sero negative persons.
        Lancet. 1984; 2: 1418
        • Schochetman G.
        • Ou C.Y.
        • Jones W.K.
        Polymerase chain reaction.
        J Infect Dis. 1988; 158: 1154
        • Schwartz J.S.
        • Dans P.E.
        • Kinosian B.M.
        Human immunodeficiency virus test evaluation, performance, and use: Proposals to make good tests better.
        JAMA. 1988; 259: 2574
        • Shoeman R.L.
        • Young D.
        • Pottahil R.
        • et al.
        Comparison of recombinant human immu nodeficiency virus gag precursor and gag-env fusion proteins and a synthetic env peptide as diagnostic reagents.
        Anal Biochem. 1987; 161: 370
        • Steimer K.S.
        • Higgins K.W.
        • Powers M.A.
        • et al.
        Recombinant polypeptide from the endonuclease region of the acquired immune deficiency syndrome retrovirus polymerase (pol) gene detects serum antibodies in most infected individuals.
        J Virol. 1986; 58: 9
        • Tedder R.S.
        • Uttley A.
        • Cheingsong-Popov R.
        Safety of immunoglobulin preparation containing anti-HTLV-III [letter].
        Lancet. 1985; 1: 815
        • Tenner-Racz K.
        • Racz P.
        • Gluckman J-C
        • et al.
        Cell-free HIV in lymph nodes of patients with AIDS and generalized lymphadenopathy [letter].
        N Engl J Med. 1988; 318: 49
        • Tersmette M.
        • Lelie P.N.
        • van der Poel C.L.
        • et al.
        Confirmation of HIV seropositivity: Comparison of a novel radioimmunoprecipitation assay to immunoblotting and virus culture.
        J Med Virol. 1988; 24: 109
        • Tindall B.
        • Barker S.
        • Donovan B.
        • et al.
        Characterization of the acute clinical illness associated with human immunodeficiency virus infection.
        Arch Intern Med. 1988; 148: 945
        • Towbin H.
        • Staehlin T.
        • Gordon J.
        Electrophoretic transfer of proteins from polyacryl amide gels to nitrocellulose sheets: Procedure and some applications.
        Proc Natl Acad Sci USA. 1979; 76: 4350
        • van der Groen G.
        • Vercauteren G.
        • Piot P.
        Immunofluorescence tests for HIV antibody and their value as confirmatory tests.
        J Virol Meth. 1987; 17: 35
        • van der Poel C.L.
        • Reesink H.
        • Lelie P.
        Persistent single reactivity against p24 gag in Western blot not associated with antibodies against HIV-1, HIV-2 or HTLV-4 encoded proteins.
        CDC AIDS Weekly. 1987; 14: 15

      98. Watkins JD: Report of the Presidential Commission on the Human Immunodeficiency Virus Epidemic. Executive summary, page XVII. Washington, D.C., U.S. Government Printing Office 1988-0-214-701:QL3

        • Wittek A.E.
        • Phelan A.
        • Wells M.A.
        • et al.
        Detection of human immunodeficiency virus core protein in plasma by enzyme immunoassay.
        Ann Intern Med. 1987; 107: 286
        • Wolfe W.H.
        • Miner J.C.
        • Armstrong F.P.
        • et al.
        More on HTLV-III antibodies in immune globulin [letter].
        JAMA. 1986; 256: 2200
        • Wood C.C.
        • Williams A.E.
        • McNamara J.G.
        • et al.
        Antibody against the human immune-deficiency virus in commercial intravenous gammaglobulin preparations.
        Ann Intern Med. 1986; 105: 536
        • Yoshida T.
        • Matsui T.
        • Kobayashi S.
        • et al.
        Evaluation of passive particle agglutination test for antibody to human immunodeficiency virus.
        J Clin Microbiol. 1987; 25: 1433
        • Zolla-Pazner S.
        • Desjarlais D.C.
        • Friedman S.R.
        • et al.
        Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: Implications for immunologic classification of the disease.
        Proc Natl Acad Sci USA. 1987; 84: 5404

      Article info

      Footnotes

      All material in this article is in the public domain with the exception of any borrowed tables and figures.

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30609-7

      Copyright

      © 1989 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX